Tuberde, Wennie, Jr. B.

HRN: 23-94-23  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
10/22/2023
10/29/2023
PO
8ml
BID
T/C UTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: